MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Effect of non-contact boxing on non-motor symptoms in Parkinson’s disease

    A. Ghaffar, R. Gallagher, L. Rubin, S. Dharia, L. Ketigian, J. Whalen, Z. Scheid, K. Patel, J. Zhu, C. Michaelides, A. Leder (Old Westbury, NY, USA)

    Objective: To determine if one session per week of Rock Steady Boxing (RSB) for 12 to 36 weeks resulted in improved cognition, mental health, activities…
  • 2019 International Congress

    Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

    J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

    Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…
  • 2019 International Congress

    Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial

    C. Mcdonald, J. Rees, K. Winge, J. Newton, D. Burn (Gateshead, United Kingdom)

    Objective: To assess the feasibility and efficacy of bladder training for troublesome lower urinary tract symptoms in Parkinson’s disease. Background: Lower urinary tract symptoms (LUTS)…
  • 2019 International Congress

    Acute unilateral involuntary movement in a patient with posterior reversible encephalopathy syndrome

    P-Y. Chen (Taipei, Taiwan)

    Objective: To describe the unusual clinical manifestations in a patient with posterior reversible encephalopathy syndrome. Background: Posterior reversible encephalopathy syndrome (PRES) is a transient clinical…
  • 2019 International Congress

    Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease

    E. Fiorenzato, A. Strafella, J. Kim, R. Schifano, L. Weis, A. Antonini, R. Biundo (Venice, Italy)

    Objective: Aim of the present study was to characterize the dynamic changes of functional connectivity associated with Parkinson’s disease (PD) cognitive decline using dynamic functional…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • 2019 International Congress

    Cerebellar Structural changes in Patients with Parkinson’s disease and Essential Tremor

    A. Lopez, P. Trujillo, B. Landman, P. Hedera, D. Claassen (Nashville, TN, USA)

    Objective: To assess differences in cerebellar lobar volumes in Essential tremor and Parkinson’s disease patients and investigate the relation of lobar volumes with motor symptoms.…
  • 2019 International Congress

    Patterns of cortical thickness, surface area and subcortical volume in Parkinson’s disease patients with freezing of gait

    T. Mi, S. Garg, A. Liu, P. Chan, M. Mckeown (Beijing, China)

    Objective: To investigate the cortical thickness, surface area and subcortical volumes changes in the fronto-parietal cortices and subcortical structures, and to obtain a representative model…
  • 2019 International Congress

    Structural imaging changes in hepatic and neurological Wilson disease

    A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)

    Objective: To quantitatively assess cerebral structural changes in Wilson disease (WD) subjects with hepatic and neurological phenotypes. Background: WD is a rare autosomal recessive disorder…
  • 2019 International Congress

    Genotype influences circuit compensation in Parkinson’s disease

    K. Schindlbeck, A. Vo, N. Nguyen, C. Tang, M. Niethammer, V. Dhawan, V. Brandt, R. Saunders-Pullman, S. Bressman, D. Eidelberg (Manhasset, NY, USA)

    Objective: This study investigates differences in brain network organization in patients with Parkinson’s disease (PD) with genetic risk factors relative to sporadic PD patients and…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley